Locks of Fortune: JW Shinyak Soars 26.71% on Hair Loss Treatment Hype
- The hair loss treatment theme has shown significant strength, rising 3.03% from the previous day.
- The hair loss treatment theme, which has been showing a strong upward trend, recently fell slightly but is now showing signs of a successful rebound.
- Stocks within the hair loss treatment theme are showing a good performance with an overall upward trend.
Hair Loss Treatment Theme Shows Strength with 3.03% Increase
The hair loss treatment theme has shown significant strength, rising 3.03% from the previous day. JW Shinyak (067290), a specialized pharmaceutical company, has attracted attention as a related stock and is rising sharply by 26.71% from the previous day.
Hair Loss Treatment Theme Expectations Recover
The hair loss treatment theme, which has been showing a strong upward trend, recently fell slightly but is now showing signs of a successful rebound. Institutions have led the theme’s upward trend with net purchases of KRW 10.6 billion, while foreigners and individuals sold KRW -2.232 billion and KRW -3.881 billion, respectively.
Trading Trends by Subject
Top Performing Stocks within the Theme
Stocks within the hair loss treatment theme are showing a good performance with an overall upward trend. In terms of increase, JW Shinyak is in the lead with 26.71%, followed by Spear Power (7.9%) and Kang Stem Biotech (3.55%).
Hair Loss Treatment Theme Major Stocks Rise and Fall Rate
JW Shinyak’s Financial Performance
JW Pharmaceutical’s quantitative financial score was 31.31 points, ranking 7th within the theme. JW Pharmaceutical had a relatively high financial profitability score, indicating its efficient profit-generating ability is better than other stocks in the theme.
Top Financial Score Stocks within the Theme
The quantitative financial score is the result of analysis by the roboalgorithm based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, and ROE.